Searchable abstracts of presentations at key conferences in endocrinology

ea0099p522 | Pituitary and Neuroendocrinology | ECE2024

Beyond idiopathic arginine vasopressin deficiency: unveiling its etiology after over a decade

Anton Patricia-Maria , Radian Serban , Cristina Căpăţină , Poiană Cătălina

Introduction: Arginine vasopressin deficiency (AVP-D) is a rare disorder with diverse etiologies. Approximately 30% of cases are labelled idiopathic, often associated with an underlying autoimmune process. This case report presents a previously presumed idiopathic AVP-D, revealing its aetiology after more than a decade of follow-up.Case presentation: A 19-year-old male presented in 2012 with symptoms of AVP-D and non-pruritic papular skin lesions on the ...

ea0086oc3.1 | Reproductive and Neuroendocrinology | SFEBES2022

Depot somatostatin receptor ligand therapy reverses tissue thyrotoxicosis in thyrotropinomas and aids microadenoma localization via 11C-Methionine PET

Koulouri Olympia , MacFarlane James , Bashari Waiel , Gillett Daniel , Senanayake Russell , Halsall David , Oddy Sue , Powlson Andrew , Serban Laura , Moran Carla , Schoenmakers Nadia , Chatterjee Krishna , Gurnell Mark

Context: Surgery is the first-line treatment option for thyrotropinomas, but medical therapy with somatostatin receptor ligands (SRL) may be used as neoadjuvant treatment and to facilitate safe surgery.Objectives: To determine the extent to which neoadjuvant SRL (i) corrects clinical, laboratory and tissue hyperthyroidism in thyrotropinomas, (ii) induces tumour shrinkage in macroadenomas, and (iii) aids microadenoma detection by 11C-methionine...

ea0090ep795 | Pituitary and Neuroendocrinology | ECE2023

Coexistence of acromegaly and autoimmune disorders: Between hazard and causality – a case series

Iftimie Mădălina Elena , Iulia-Florentina Burcea , Dobre Ramona , Trifanescu Raluca , Niculescu Dan Alexandru , Baciu Ionela , Radian Serban , Capatana Cristina , Poiana Catalina

Introduction: Acromegaly is a rare, chronic endocrinopathy, that results from persistent hypersecretion of growth hormone (GH) and consequently of insulin-like growth factor 1 (IGF1). It is well known that GH excess has multisystemic effects throughout the body, but its interaction with the immune system has only been suggested in the last few decades. This prompted us to explore the frequency of autoimmune disorders in a retrospective acromegaly cohort....

ea0090ep851 | Pituitary and Neuroendocrinology | ECE2023

Echocardiographic features in patients with prolactinoma long-term treated with dopamine agonists

Carmen Giuca Diandra , Constantin Vere Cristin , Nitu Ileana , Capatina Cristina , Baciu Ionela , Florentina Burcea Iulia , Baculescu Nicoleta , Radian Serban , Simona Andreea Găloiu , Trifanescu Raluca , Poiana Catalina

Background: Dopamine agonists (DAs) were associated with valvular dysfunction in patients with Parkinson’s disease due to their fibrotic effect through the serotoninergic receptor. It is more difficult to prove the same effects in patients with prolactinoma due to the lower doses, variable doses and the longer follow-up period. Aim: To assess echocardiographic features in patients with prolactinoma under DA treatment.Methods: ...

ea0063gp165 | Obesity (1) | ECE2019

Role of invasive and non-invasive diagnostic tests in differential diagnosis of ACTH-dependent Cushing’s syndrome

Barbot Mattia , Ferrante Emanuele , Ceccato Filippo , Daniele Andrea , Lizzul Laura , Cuman Margherita , Monteleone Valerio , Serban Andreea , Sala Elisa , Locatelli Marco , Arosio Maura , Boscaro Marco , Scaroni Carla , Mantovani Giovanna

Background: Differential diagnosis of ACTH-dependent hypercortisolism is crucial to indicate a proper treatment and is based on CRH-, high-dose dexamethasone suppression-test (HDDST) and pituitary MRI. However, up to 50% of cases of Cushing’s disease (CD) present a negative MRI or a visible lesion < 6 mm. In these patients, guidelines suggest to perform bilateral inferior petrosal sinus sampling (BIPSS) in order to establish a correct diagnosis. Aim of this study was ...

ea0063p648 | Interdisciplinary Endocrinology 1 | ECE2019

Ghrelin expression in breast carcinomas

Armasu Ioana , Ciobanu Delia-Gabriela , Ianole Victor , Vasiliu Ioana , Hristov Ioana , Leustean Letita , Lupascu Cristian , Mocanu Veronica , Serban Ionela Lacramioara , Preda Cristina

Introduction: Breast cancer is, by far, the most frequent cancer among women. Local and systemic factors have been shown to drive growth in breast cancer cells. There is increasing evidence that hormone ghrelin, known for the growth hormone releasing effect and food intake modulator, may also influence cancer growth. Ghrelin has been shown to be produced by some tumor cells, including breast cancer cells.Objective: To analyze ghrelin expression in correl...

ea0063p1063 | Pituitary and Neuroendocrinology 3 | ECE2019

Cumulative GH exposure as risk factor for mortality and morbidity in patients with acromegaly

Galoiu Simona , Silea Simona , Mailat Monica , Baciu Ionela , Trifanescu Raluca Alexandra , Niculescu Dan Alexandru , Capatina Cristina , Radian Serban , Baculescu Nicoleta , Caragheoorgheopol Andra , Dumitrascu Anda , Poiana Catalina

Background: In patients with acromegaly, mortality depends most on achievement of control of GH/IGF1 levels. However, some of the complications of acromegaly still develop, despite successful control of disease. The aim of the study is to correlate mortality and morbidity with cumulative GH exposure in these patients compared to last GH/IGF1 level.Methods: We studied retrospectively 336 patients with acromegaly consecutively evaluated at least twice duri...

ea0070aep663 | Pituitary and Neuroendocrinology | ECE2020

Efficacy of monotherapy versus combined GH receptor antagonist therapy in patients with somatostatin receptor analogues resistant acromegaly

Simona Andreea Găloiu , Margarit Emma , Lavinia Popa Maria , Baciu Ionela , Niculescu Dan , Trifanescu Raluca , Serban Radian , Dumitrașcu Anda , Caragheorgheopol Andra , Poiana Catalina

Background and Aims: GH receptor antagonist (Pegvisomant –PEG) has been shown to obtain IGF1 normalization in 60–90% of patients with acromegaly in clinical trials. The aim of the study is to evaluate real life response and side effects of PEG treatment in monotherapy versus combined with somatostatin analogues and/or cabergoline in patients with somatostatin analogues resistant acromegaly.Methods: We included 40 patients (22F/18 M) cons...

ea0070aep679 | Pituitary and Neuroendocrinology | ECE2020

Role of NGS in the diagnostic work-up of pituitary tumors and ‘incidental findings’

Del Sindaco Giulia , Sala Elisa , Carosi Giulia , Cremaschi Arianna , Mungari Roberta , Liliana Serban Andreea , Mantovani Beatrice , Indirli Rita , Ferrante Emanuele , Persani Luca , Arosio Maura , Mantovani Giovanna

Background: Pituitary tumors are mostly sporadic, but in less than 5% of cases they can be associated to genetic syndromes, so harbouring germline mutations. Familial pituitary tumors are often more aggressive, so it’s important to detect them, for both a better early diagnosis and genetic counselling. Before the development of Next-Generation Sequencing (NGS), Sanger sequencing was the most widely used method of DNA sequencing. Therefore, DNA samples were analysed follo...

ea0070aep734 | Pituitary and Neuroendocrinology | ECE2020

Use of tolvaptan in acute post-surgical hyponatremia in patients with pituitary diseases

Ferrante Emanuele , Indirli Rita , Mantovani Beatrice , Cremaschi Arianna , Liliana Serban Andreea , Sala Elisa , Locatelli Marco , Bertani Giulio , Arosio Maura , Mantovani Giovanna

Introduction: Hypotonic hyponatremia is frequently observed after pituitary surgery. In this context, use of vasopressin V2-receptor antagonists is not standardized. The aim of this retrospective study is to explore the role of Tolvaptan in the management of acute hyponatraemia after pituitary surgery.Methods: We collected clinical, safety and efficacy data of patients treated with Tolvaptan after pituitary surgeryin our Centre between April 2011 and Feb...